Department of Orthopaedic Surgery, Faculty of Medicine and Graduate School of Medicine, Hokkaido University, Sapporo, Japan.
Global Station of Soft Matter, Global Institution for Collaborative Research and Education (GSS, GI-CoRE), Sapporo, Japan.
Am J Sports Med. 2021 Jul;49(8):2199-2210. doi: 10.1177/03635465211014186. Epub 2021 Jun 1.
Ultrapurified alginate (UPAL) gel implantation has been demonstrated as effective in cartilage repair for osteochondral defects; however, cell transplantation within UPAL gels would be required to treat larger defects.
The combination of UPAL gel and bone marrow aspirate concentrate (BMAC) would enhance cartilage repair and subchondral bone repair for large osteochondral defects.
Controlled laboratory study.
A total of 104 osteochondral defects (1 defect per knee) of 52 rabbits were randomly divided into 4 groups (26 defects per group): defects without any treatment (Defect group), defects treated using UPAL gel alone (UPAL group), defects treated using UPAL gel containing allogenic bone marrow mesenchymal stromal cells (UPAL-MSC group), and defects treated using UPAL gel containing BMAC (UPAL-BMAC group). At 4 and 16 weeks postoperatively, macroscopic and histologic evaluations and measurements of repaired subchondral bone volumes of reparative tissues were performed. Collagen orientation and mechanical properties of the reparative tissue were assessed at 16 weeks.
The defects in the UPAL-BMAC group were repaired with hyaline-like cartilage with well-organized collagen structures. The histologic scores at 4 weeks were significantly higher in the UPAL-BMAC group (16.9 ± 2.0) than in the Defect group (4.7 ± 1.9; < .05), the UPAL group (10.0 ± 3.3; < .05), and the UPAL-MSC group (12.2 ± 2.9; < .05). At 16 weeks, the score in the UPAL-BMAC group (24.4 ± 1.7) was significantly higher than those in the Defect group (9.0 ± 3.7; < .05), the UPAL group (14.2 ± 3.9; < .05), and the UPAL-MSC group (16.3 ± 3.6; < .05). At 4 and 16 weeks, the macroscopic evaluations were significantly superior in the UPAL-BMAC group compared with the other groups, and the values of repaired subchondral bone volumes in the UPAL-BMAC group were significantly higher than those in the Defect and UPAL groups. The mechanical properties of the reparative tissues were significantly better in the UPAL-BMAC group than in the other groups.
The implantation of UPAL gel containing BMAC-enhanced hyaline-like cartilage repair and subchondral bone repair of osteochondral defects in a rabbit knee model.
These data support the potential clinical application of 1-step treatment for large osteochondral defects using biomaterial implantation with cell transplantation.
超纯藻酸盐(UPAL)凝胶植入已被证明在治疗骨软骨缺损的软骨修复中是有效的;然而,需要在 UPAL 凝胶内进行细胞移植以治疗更大的缺损。
UPAL 凝胶和骨髓抽吸浓缩物(BMAC)的组合将增强大骨软骨缺损的软骨修复和软骨下骨修复。
对照实验室研究。
共对 52 只兔子的 104 个骨软骨缺损(每只膝关节 1 个缺损)进行了随机分组(每组 26 个缺损):无任何治疗的缺损(缺损组)、单独使用 UPAL 凝胶治疗的缺损(UPAL 组)、单独使用 UPAL 凝胶和同种异体骨髓间充质基质细胞治疗的缺损(UPAL-MSC 组)以及单独使用 UPAL 凝胶和 BMAC 治疗的缺损(UPAL-BMAC 组)。术后 4 周和 16 周时,对修复的软骨下骨体积进行大体和组织学评估和测量。在 16 周时评估修复组织的胶原取向和力学性能。
UPAL-BMAC 组的缺损用类似透明软骨的软骨修复,胶原结构排列整齐。组织学评分在 4 周时 UPAL-BMAC 组(16.9 ± 2.0)明显高于缺损组(4.7 ± 1.9;<0.05)、UPAL 组(10.0 ± 3.3;<0.05)和 UPAL-MSC 组(12.2 ± 2.9;<0.05)。在 16 周时,UPAL-BMAC 组的评分(24.4 ± 1.7)明显高于缺损组(9.0 ± 3.7;<0.05)、UPAL 组(14.2 ± 3.9;<0.05)和 UPAL-MSC 组(16.3 ± 3.6;<0.05)。在 4 周和 16 周时,与其他组相比,UPAL-BMAC 组的大体评估明显更优,并且 UPAL-BMAC 组修复的软骨下骨体积值明显高于缺损组和 UPAL 组。修复组织的力学性能在 UPAL-BMAC 组明显优于其他组。
在兔膝关节模型中,植入 UPAL 凝胶联合 BMAC 增强了透明样软骨修复和软骨下骨修复。
这些数据支持在使用细胞移植的生物材料植入的情况下,对大的骨软骨缺损进行 1 步治疗的潜在临床应用。